Altrius Global Dividend ETF (DIVD) Chart & Stock Price History → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free DIVD Stock Alerts $32.77 +0.13 (+0.40%) (As of 05/7/2024 ET) Add Compare Share Share ChartStock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestSocial Media Altrius Global Dividend ETF Stock Price Performance5 Day Performance+0.97%1 Month Performance-1.11%3 Month Performance+3.91%6 Month Performance+14.03%Year-To-Date Performance+3.26%1 Year Performance+11.15% Receive DIVD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Altrius Global Dividend ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide DIVD Stock Chart for Wednesday, May, 8, 2024 DIVD Chart by TradingView Altrius Global Dividend ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$32.64$32.77+0.41%$32.77$32.779 shs$6.88 million05/06/2024$32.46$32.64+0.56%$32.64$32.554,869 shs$6.85 million05/03/2024$32.30$32.46+0.50%$32.46$32.36100 shs$6.82 million05/02/2024$32.12$32.30+0.54%$32.30$32.162,842 shs$6.78 million05/01/2024$32.12$32.12+0.01%$32.12$32.07197 shs$6.75 million04/30/2024$32.64$32.12-1.59%$32.12$32.1289 shs$6.75 million Get the Latest News and Ratings for DIVD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Altrius Global Dividend ETF and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$32.40$32.64+0.75%$32.66$32.644,358 shs$6.85 million04/26/2024$32.50$32.40-0.32%$32.40$32.4025 shs$6.80 million04/25/2024$32.68$32.50-0.56%$32.50$32.5017 shs$6.83 million04/24/2024$32.71$32.68-0.08%$32.68$32.6810 shs$6.86 million04/23/2024$32.43$32.71+0.88%$32.71$32.681,529 shs$6.87 million04/22/2024$32.18$32.43+0.75%$32.43$32.433 shs$6.81 million04/19/2024$31.95$32.18+0.72%$32.18$32.17329 shs$6.76 million04/18/2024$31.96$31.95-0.02%$32.01$31.903,708 shs$6.71 million04/17/2024$31.92$31.96+0.11%$31.96$31.96135 shs$6.71 million04/16/2024$32.21$31.92-0.90%$31.92$31.926 shs$6.70 million04/15/2024$32.27$32.21-0.16%$32.21$32.21457 shs$6.77 million04/12/2024$32.79$32.27-1.61%$32.27$32.241,172 shs$6.78 million04/11/2024$32.81$32.79-0.06%$32.79$32.77785 shs$6.89 million04/10/2024$33.15$32.81-1.01%$32.89$32.761,257 shs$6.89 million04/09/2024$33.14$33.15+0.02%$33.15$33.04126 shs$6.96 million04/08/2024$33.15$33.14-0.02%$33.16$33.14207 shs$6.96 million04/05/2024$33.09$33.15+0.19%$33.15$33.08206 shs$6.96 million04/04/2024$33.36$33.09-0.81%$33.51$33.09523 shs$7.28 million04/03/2024$33.27$33.36+0.28%$33.36$33.33223 shs$7.34 million04/02/2024$33.40$33.27-0.41%$33.27$33.2712 shs$7.32 million04/01/2024$33.55$33.40-0.45%$33.48$33.404 shs$7.35 million03/29/2024$33.55$33.55$33.55$33.55189 shs$7.38 million03/28/2024$33.47$33.55+0.25%$33.55$33.55189 shs$7.38 million03/27/2024$33.06$33.47+1.23%$33.47$33.261,094 shs$7.36 million03/26/2024$33.23$33.06-0.50%$33.06$33.0610 shs$7.27 million03/25/2024$33.23$33.23+0.01%$33.23$33.233 shs$7.31 million03/22/2024$33.29$33.23-0.18%$33.28$33.021,149 shs$7.31 million03/21/2024$33.22$33.29+0.21%$33.29$33.2919 shs$7.32 million03/20/2024$32.94$33.22+0.84%$33.22$32.89389 shs$7.31 million03/19/2024$32.81$32.94+0.39%$32.94$32.9471 shs$7.25 million03/18/2024$32.80$32.81+0.03%$32.85$32.81822 shs$7.22 million03/15/2024$32.74$32.80+0.19%$32.80$32.8069 shs$7.22 million03/14/2024$32.95$32.74-0.64%$32.78$32.74163 shs$7.20 million03/13/2024$32.92$32.95+0.09%$32.95$32.9518 shs$7.25 millionThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read03/12/2024$32.74$32.92+0.55%$32.92$32.82938 shs$7.24 million03/11/2024$32.57$32.74+0.52%$32.74$32.681,506 shs$7.20 million03/08/2024$32.62$32.57-0.15%$32.62$32.571,205 shs$7.17 million03/07/2024$32.36$32.62+0.80%$32.62$32.62175 shs$7.18 million03/06/2024$32.18$32.36+0.56%$32.36$32.361,436 shs$7.12 million03/05/2024$32.23$32.18-0.16%$32.26$32.181,436 shs$7.08 million03/04/2024$32.17$32.23+0.19%$32.23$32.2381 shs$7.09 million03/01/2024$32.02$32.17+0.47%$32.17$32.12366 shs$7.08 million02/29/2024$31.91$32.02+0.34%$32.02$32.02100 shs$7.04 million02/28/2024$32.00$31.91-0.27%$31.93$31.91201 shs$7.02 million02/27/2024$32.08$32.00-0.26%$32.00$31.93191 shs$7.04 million02/26/2024$32.25$32.08-0.53%$32.08$32.0815 shs$7.06 million02/23/2024$32.09$32.25+0.50%$32.25$32.2595 shs$7.10 million02/22/2024$31.87$32.09+0.70%$32.09$32.01226 shs$7.06 million02/21/2024$31.75$31.87+0.38%$31.87$31.8754 shs$7.01 million02/20/2024$31.71$31.75+0.12%$31.75$31.751 shs$6.98 million02/19/2024$31.71$31.710.00%$31.78$31.71700 shs$6.98 million02/16/2024$31.72$31.71-0.03%$31.78$31.71771 shs$6.98 million02/15/2024$31.38$31.72+1.08%$31.72$31.60574 shs$6.98 million02/14/2024$31.24$31.38+0.45%$31.38$31.3894 shs$6.90 million02/13/2024$31.70$31.24-1.45%$31.50$31.24200 shs$6.87 million02/12/2024$31.51$31.70+0.59%$31.76$31.571,132 shs$6.97 million02/09/2024$31.54$31.51-0.10%$31.51$31.46313 shs$6.93 million02/08/2024$31.57$31.54-0.10%$31.54$31.49867 shs$6.94 million02/07/2024$31.59$31.57-0.06%$31.63$31.57573 shs$6.95 million Related Companies: Global X MSCI SuperDividend EAFE ETF Stock Price Chart VictoryShares International High Div Volatility Wtd ETF Stock Price Chart First Trust Dividend Strength ETF Stock Price Chart WisdomTree Emerging Markets Quality Dividend Growth Fund Stock Price Chart WisdomTree U.S. SmallCap Quality Dividend Growth Fund Stock Price Chart First Trust BuyWrite Income ETF Stock Price Chart Franklin U.S. Low Volatility High Dividend Index ETF Stock Price Chart Invesco Dividend Achievers ETF Stock Price Chart VictoryShares US EQ Income Enhanced Volatility Wtd ETF Stock Price Chart Invesco International Dividend Achievers ETF Stock Price Chart Receive DIVD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Altrius Global Dividend ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DIVD) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Altrius Global Dividend ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.